Delmas Pharmaceuticals Private Limited

Delmas Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U33100RJ2021PTC072862 Incorporated 08 January 2021 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹13.12 Lakh
▲ 13% YoY
Net profit · FY 2024
₹6,210
Net margin 0.5%
EBITDA · FY 2024
₹10,840
EBITDA margin 0.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Delmas Pharmaceuticals Private Limited

Data last updated:

Delmas Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 January 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33100RJ2021PTC072862. Its GSTIN is 09AAICD2423R1Z7 (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuj Kumar and Ashutosh Gaur.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020.

As per the financials filed for FY 2024, the company reported a revenue of ₹13.12 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹6,210 (net margin 0.5%) and EBITDA of ₹10,840 (EBITDA margin 0.8%).

Delmas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0039363).

Company details

CIN U33100RJ2021PTC072862
Registration Number 072862
Incorporation Date 08 January 2021
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0039363

Recognitions & Rankings of Delmas Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-RJ-17-0039363

Contact details

Delmas Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.

  • Email
  • Registered Address
    F – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Delmas Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Delmas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Delmas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Delmas Pharmaceuticals Private Limited, buy the company report.

Financials of Delmas Pharmaceuticals Private Limited

FY 2025 filings available

Delmas Pharmaceuticals Private Limited reported revenue of ₹13.12 Lakh (up 13% YoY) for FY 2024.

Revenue · FY 2024
₹13.12 Lakh ▲ 13%
Net profit · FY 2024
₹6,210 margin 0.5%
EBITDA · FY 2024
₹10,840 margin 0.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 13%
EBITDA CAGR growth
1 year
▼ 83%

Revenue rose 13% in the latest year. EBITDA fell 83% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10,840
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6,210
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.8%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Delmas Pharmaceuticals Private Limited, buy the company report.

Board of directors of Delmas Pharmaceuticals Private Limited

Delmas Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuj KumarDirector08 Jan 20215 Years 10 MonthsCurrent
Ashutosh GaurDirector08 Jan 20215 Years 10 MonthsCurrent

Peer comparison

Delmas Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
KBD Pharmaceuticals Private Limited₹13.15 Lakh (FY 2023)10.0%Hyderabad, Telangana, India
Kestrel Pharmaceuticals Private Limited₹13.14 Lakh (FY 2025)-26.0%Jail Road, Kerala, India
Sridhara Life Sciences Private Limited₹13.13 Lakh (FY 2021)-98.0%Indore, Madhya Pradesh, India
Delmas Pharmaceuticals Private Limitedthis company₹13.12 Lakh (FY 2024)₹6,2100.5%13.0%Jaipur, Rajasthan, India
Gynus Pharmaceuticals Private Limited₹13.1 Lakh (FY 2025)0.0%Allahabad, Uttar Pradesh, India
Indu Pharma Private Limited₹13.1 Lakh (FY 2019)8.0%Balanagar, Hyderabad - 37, Andhra Pradesh, India

To see the full peer comparison of Delmas Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Delmas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Delmas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAICD2423R1Z7Uttar PradeshActive02 Aug 2021

To see the full GST registrations and return filing status of Delmas Pharmaceuticals Private Limited, buy the company report.

Recent activity

Delmas Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anuj Kumar was appointed as Director on 08 Jan 2021.

AGM
Delmas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Delmas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Anuj Kumar was appointed as Director.
Appointed
Ashutosh Gaur was appointed as Director.
Incorporation
08 Jan 2021
Delmas Pharmaceuticals Private Limited was registered on 08 Jan 2021 with Roc Jaipur & aged 5 years 10 months as per MCA records.

Frequently asked questions

Delmas Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 January 2021 (5+ years old) and is registered under CIN U33100RJ2021PTC072862.

Delmas Pharmaceuticals has 2 current directors:

The latest financial statements of Delmas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Delmas Pharmaceuticals is 09AAICD2423R1Z7, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Delmas Pharmaceuticals is U33100RJ2021PTC072862. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Delmas Pharmaceuticals was incorporated on 08 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Delmas Pharmaceuticals by revenue are KBD Pharmaceuticals Private Limited, Kestrel Pharmaceuticals Private Limited, Sridhara Life Sciences Private Limited, Gynus Pharmaceuticals Private Limited, Indu Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anuj Kumar was appointed as Director on 08 Jan 2021. Ashutosh Gaur was appointed as Director on 08 Jan 2021.

Yes, Delmas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0039363).

The registered office of Delmas Pharmaceuticals is at F – 255 – A RIICO Mansarovar, Jaipur, Rajasthan, India – 302020.

Delmas Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.